Results 161 to 170 of about 29,271 (207)

Pathogenetic Mechanism of Macular Edema During Treatment with Ibrutinib. [PDF]

Mediterr J Hematol Infect Dis
Mauro C, Pupo L, Cardillo L, Esposito F, Buzzatti E, Lombardo M, Cesareo M, Venditti A, Postorino M, Del Principe MI.   +9 more
europepmc   +1 more source

Is Brukinsa (Zanubrutinib) a Safer Bruton's Tyrosine Kinase (BTK) Inhibitor in Relapsed or Refractory Chronic Lymphocytic Leukemia? A Systematic Review and Meta-Analysis. [PDF]

Pharmaceuticals (Basel)
Hetta HF, Salama A, Aljuaid TA, Mojmami YT, Alotibi RS, Alqabaly AM, Aldosari NA, Alshahri SA, Asiri WIA, Alamri RS, Alanazi FA, Alenazi MSA, Albuhayri MH, Ramadan YN, Sayad R.   +14 more
europepmc   +1 more source

Zanubrutinib for the treatment of patients with del(17p) and/or TP53 CLL/SLL: analysis across clinical studies. [PDF]

Blood Adv
Tam CS, Anderson MA, Šimkovič M, Ghia P, Flinn IW, Laribi K, Opat S, Cull G, Munir T, Österborg A, Tedeschi A, Wang M, Szeto A, Allewelt H, Salmi T, Li J, Xu L, Wu K, Vezan R, Shadman M, Brown JR.   +20 more
europepmc   +1 more source

Refining prognostic tools in Waldenström macroglobulinemia. [PDF]

Blood Adv
Lionel AC, Thomas SK.
europepmc   +1 more source

A retrospective analysis of outpatient use of small-molecule targeted inhibitors for lymphoma across six regions of China (2016-2022). [PDF]

Front Pharmacol
Chen B, Chen LY, Chen P, Wang C, Yang CW, Hu Y, Wei R, Li LC, Fu ZL.   +8 more
europepmc   +1 more source

A case report of hemophagocytic lymphohistiocytosis occurring during ibrutinib chemotherapy with a literature review. [PDF]

Medicine (Baltimore)
Hou X, Wang M, Miao S, Guo Y.
europepmc   +1 more source

Advancements in research on the cardiovascular toxicity caused by TEC family kinases inhibitors. [PDF]

Front Pharmacol
Zhang Y, Fu H, Kang X, Qiu Z, Yan H, He Q, Yang B, Xu Z, Luo P.   +8 more
europepmc   +1 more source

Correction to: Significance of targeting DNMT3A mutations in AML. [PDF]

Ann Hematol
Huang G, Cai X, Li D.
europepmc   +1 more source

Ibrutinib-Associated Liver Injury in a Patient with Chronic Lymphocytic Leukemia: Clinical Course and Therapeutic Approach. [PDF]

Hematol Rep
Frolli A, Parvis G, Bullo M, Grano S, Fornari G, Bonuomo V, Cilloni D, Fava C.   +7 more
europepmc   +1 more source

Clinical practice guidelines for the diagnosis and management of chronic lymphocytic leukemia in Saudi Arabia: consensus statement by an expert panel. [PDF]

Front Med (Lausanne)
Alotaibi G, Aleem A, Absi A, Alaskar AS, Alfraih F, Alhejazi A, Almasari A, Alzahrani MF, Motabi I, El Fakih R.   +9 more
europepmc   +1 more source